ASIT biotech has installed and qualified a clean room with the equipment to produce, in compliance with GMP requirements, the API for the Phase I/II studies in house dust mite and peanut allergies treatment.     The availability of a dedicated GMP manufacturing unit reduces the technology transfer duration and improves the flexibility and the agility of such transfer from the R&D to production thanks to the “real-time” fine-tuning opportunities. It also lifts the constraints related ...